. Despite the identification of many components of this pathway, it remains unclear how the BR signal is transduced from the cell surface to the nucleus 2 . Here we describe a complete BR signalling pathway by elucidating key missing steps. We show that phosphorylation of BSK1 (BR-signalling kinase 1) by the BR receptor kinase BRI1 (BRinsensitive 1) promotes BSK1 binding to the BSU1 (BRI1 suppressor 1) phosphatase, and BSU1 inactivates the GSK3-like kinase BIN2 (BR-insensitive 2) by dephosphorylating a conserved phospho-tyrosine residue (pTyr 200). Mutations that affect phosphorylation/dephosphorylation of BIN2 pTyr200 (bin2-1, bin2-Y200F and quadruple loss-of-function of BSU1-related phosphatases) support an essential role for BSU1-mediated BIN2 dephosphorylation in BR-dependent plant growth. These results demonstrate direct sequential BR activation of BRI1, BSK1 and BSU1, and inactivation of BIN2, leading to accumulation of unphosphorylated BZR (brassinazole resistant) transcription factors in the nucleus. This study establishes a fully connected BR signalling pathway and provides new insights into the mechanism of GSK3 regulation.
. Although many components have been identified and studied in detail, our understanding of the BR signalling pathway remains incomplete, with major gaps between the receptor kinases at the cell surface and downstream components in the cytoplasm and nucleus ( Supplementary Information, Fig. S1a ) 1, 2 . The upstream BR-signalling components at the plasma membrane include BRI1 (refs 5, 6 ) and BAK1 (BR-insensitive 1-associated receptor kinase 1; refs 7, 8) receptor kinases, a new protein, BKI1, that inhibits BRI1 (ref. 9 ) and the plasma membrane-associated BR-signalling kinases (BSKs) 10 . BR binding to the extracellular domain of BRI1 causes disassociation of BKI1 from BRI1 (ref. 9, 11) and induces association and trans-phosphorylation between BRI1 and its co-receptor BAK1 (ref. 12 ), leading to activation of BRI1 kinase and phosphorylation of its BSK substrates 10 . Proteomic and genetic studies have demonstrated an essential role for BSKs in transducing the signal to the downstream components, but their direct target remains unknown 10 . Downstream BR signalling involves the GSK3-like kinase BIN2 (ref. 13) , the Kelch-repeats-containing phosphatase BSU1 (ref. 14) , the 14-3-3 family of phosphopeptide-binding proteins 15 , and BZR1 and BZR2, which directly bind to DNA and regulate BR-responsive gene expression [16] [17] [18] [19] . As a negative regulator of BR signalling, BIN2 phosphorylates BZR1 and BZR2 at numerous sites to inhibit their activities through several mechanisms 2 . These include accelerating proteasome-mediated degradation 20 , promoting nuclear export and cytoplasmic retention by the 14-3-3 proteins 15, 21 , and inhibiting DNA binding and transcriptional activity 2, 15, 22 . By contrast, the BSU1 phosphatase is a positive regulator of BR signalling 14 . Overexpression of BSU1 increases dephosphorylated BZR2 and activates BR responses 4, 14 . However, BSU1 does not interact with or effectively dephosphorylate BZR2 in vitro and the biochemical function of BSU1 remains unknown 4, 14 . It is believed that BR induces rapid dephosphorylation of BZR1 and BZR2 by inhibiting BIN2 and/or activating BSU1. However, the mechanisms by which upstream BR signalling regulates BIN2 and BSU1 remain unclear ( Supplementary Information, Fig. S1a ) 2, 23 . To understand how BR signalling regulates BIN2, we analysed BR-induced changes in BIN2 phosphorylation using immunoblotting of two-dimensional gel electrophoresis and found that treatment with brassinolide (the most active form of BR) caused disappearance of the acidic forms and an increase in the basic forms of epitope-tagged BIN2 (Fig. 1a) , suggesting that BR induced dephosphorylation of BIN2. This result led us to investigate the role of BSU1 phosphatase in BR regulation of BIN2. Both BSU1 and its closest homologue BSL1 promote BR signalling in vivo ( Supplementary Information, Fig. S2a ) 14 , and failed to dephosphorylate BZR1 and BZR2 when added after BIN2 and ATP had been removed from the kinase reaction ( Fig. 1b ; Supplementary  Information, Fig. S3c, d ). In contrast, BSU1 most effectively reduced BZR1 phosphorylation when pre-incubated with BIN2 before adding BZR1 (Fig. 1c) . Partially phosphorylated BZR1, by BIN2 using radioactive [γ- 32 P] ATP, was further phosphorylated by BIN2 using non-radioactive ATP, causing a mobility shift of the pre-labelled BZR1. Addition of BSU1 did not reduce the radioactivity of 32 P-labelled BZR1, but abolished the mobility shift of the BZR1 band caused by BIN2 (Fig. 1d) . These results indicate that BSU1 inhibits BIN2 kinase activity, but does not dephosphorylate prephosphorylated BZR1 in vitro. The phosphatase domain of BSU1 reduced BIN2 phosphorylation of BZR1 whereas the Kelch repeat domain showed no effect ( Supplementary Information, Fig. S3e )
We next examined whether BR and the bin2-1 mutation affect BSU1 inhibition of BIN2. A BSU1-YFP (yellow fluorescent protein) fusion protein was immunoprecipitated from transgenic Arabidopsis thaliana. Similarly to recombinant GST (glutathione S-transferase)-BSU1, (-BL) for 2 h were analysed by two-dimensional gel electrophoresis before immunoblotting using an anti-peroxidase antibody that detects TAP-BIN2. (b) BSU1 does not dephosphorylate pBZR1 in vitro. BIN2-phosphorylated MBP-BZR1 (BIN2 removed) was incubated with GST, GST-BSU1 or GST-BSL1 for 12 h and analysed by immunoblotting using an anti-MBP antibody. (c-e) BSU1 inhibits BIN2 but not bin2-1. (c) GST-BIN2 was preincubated with GST-BSU1 or GST for the indicated times before MBP-BZR1 and [γ- BSU1-YFP from plants did not dephosphorylate the pre-phosphorylated BZR1 ( Supplementary Information, Fig. S4a ), but reduced BZR1 phosphorylation when co-incubated with BIN2 and BZR1 ( Supplementary  Information, Fig. S4b ) or pre-incubated with BIN2 before adding to BZR1 (Fig. 1e) . Moreover, BSU1-YFP from plants treated with brassinolide more effectively inhibited BIN2 phosphorylation of BZR1 than that from untreated plants ( Fig. 1e; Supplementary Information, Fig. S4b ), suggesting that BR activates BSU1. The gain-of-function bin2-1 mutation that causes BR-insensitive phenotypes 23 blocked regulation by BSU1-YFP in vitro (Fig. 1e) .
Several experiments demonstrated that BSU1 directly interacts with BIN2. First, GST-BIN2 was detected on a gel blot by MBP (maltosebinding protein)-BSU1 and an anti-MBP antibody (Fig. 1f) . Second, in vivo interaction was demonstrated by bimolecular fluorescence complementation (BiFC) assays 24 in which tobacco cells cotransformed with BIN2 fused to the amino-terminal half (nYFP) and BSU1 fused to carboxy-terminal half (cYFP) of YFP showed strong fluorescence signals (Fig. 1g) . Furthermore, epitope-tagged BIN2 and BSU1 were co-immunoprecipitated and the amount of co-immunoprecipitation was increased by BR treatment (Fig. 1h, i; Supplementary Information,  Fig. S5a ), indicating that upstream BR signalling induces BSU1 binding to BIN2. Similarly, BSL1 also interacted with BIN2 in BiFC and coimmunoprecipitation assays (Fig. 1g, h ). The bin2-1 mutant protein also interacted with BSU1 and BSL1 in these assays ( Fig. 1f ; Supplementary  Information, Fig. S5a, b) , suggesting that the bin2-1 mutation blocks BSU1 regulation of BIN2 without abolishing their physical interaction.
A BSU1-GFP (green fluorescent protein) fusion protein was previously observed only in the nucleus 14 . In this study, the BSU1-YFP protein was detected predominantly in the nucleus and weakly in the cytoplasm. Interestingly, BSL1-YFP was excluded from the nucleus and localized exclusively in the cytoplasm and plasma membrane ( Fig. 1g ; Supplementary  Information, Fig. S5c ). BSL1 and its two other homologues have all been identified as plasma membrane proteins by recent proteomics studies 25 , suggesting that members of the BSU family can mediate upstream BR signalling at the plasma membrane as well as funtion in the cytoplasm and nucleus.
We further examined whether BSU1 inhibits BIN2 activity in vivo. We reported previously that BIN2 phosphorylation of BZR1 promotes BZR1 cytoplasmic retention by the 14-3-3 proteins whereas unphosphorylated BZR1 accumulates in the nucleus 15 . Co-expression of BIN2 with BZR1-YFP increased phosphorylation and cytoplasmic retention of BZR1-YFP. Such an effect of BIN2, but not of bin2-1, was cancelled by co-expression with BSU1 but not with mutant BSU1 (BSU1 D510N ), which has reduced phosphatase activity but normal localization ( Fig. 2a, b ; Supplementary  Information, Fig. S6a, b) .
It was reported recently that BR treatment induces proteasome-mediated degradation of BIN2 (ref. 23) . We showed that BR treatment or overexpression of BSU1-YFP, but not the mutant BSU1 D510N , decreased the protein level of BIN2-Myc, but not of bin2-1 ( Fig. 2c, d ; Supplementary Information, Fig. S6c-f ). Consistent with a BSU1 function upstream of BIN2 and downstream of BRI1, overexpression of BSU1 partly suppressed the dwarf phenotype of the bri1-116 null mutant but not that of the homozygous bin2-1 mutant ( Fig. 2e, f; Supplementary Information, Fig. S7 ). Furthermore, expression of the BES1-target gene, SAUR-AC1 (ref. 19) , is increased in BSU1-YFP/bri1-116 plants (Fig. 2g ). These results demonstrate that BSU1 functions between BRI1 and BIN2 in the BR signal transduction pathway.
The direct interaction and the requirement of phosphatase activity of BSU1 suggest that BSU1 inhibits BIN2 by dephosphorylating BIN2. We analysed the autophosphorylation sites of BIN2 in vitro using mass spectrometry, and identified pTyr 200 of BIN2 as a major phosphorylation site ( Supplementary Information, Fig. S8a ). The same residue was recently detected as an in vivo phosphorylation site of BIN2 by a phosphoproteome analysis of Arabidopsis Y200A mutation or the kinase-inactivating M115A mutation ( Fig. 4b ; Supplementary Information, Fig. S8c ), indicating specificity for the pTyr 200 residue of BIN2. Immunoblot experiments using this antibody showed that BSU1 greatly reduced Tyr 200 phosphorylation of wild-type BIN2, but not that of the mutant bin2-1 (Fig. 3b, c) . Brassinolide treatment also reduced in vivo phosphorylation of Tyr 200 of BIN2 but not that of bin2-1 (Fig. 3d, e ). These results demonstrate that BR signalling inhibits BIN2 through BSU1-mediated dephosphorylation of pTyr 200, and that the bin2-1 mutation causes BR insensitivity by blocking this dephosphorylation.
To further confirm the role of Tyr 200 phosphorylation in BIN2 regulation, a Y200F mutation was generated. Whereas overexpression of wild-type BIN2 or mutant bin2-1 caused BR-insensitive dwarf phenotypes in transgenic Arabidopsis plants, overexpression of BIN2 or bin2-1 containing the Y200F mutation did not (Fig. 3f, g ), indicating that Tyr 200 phosphorylation is essential for BIN2 to inhibit BR-dependent plant growth and that dephosphorylation of pTyr 200 is sufficient to inactivate BIN2. Consistent with an essential role of BSU1 and its homologues in inhibiting BIN2, suppressing BSL2 and BSL3 expression in the bsu1;bsl1 double mutant caused a severe dwarf phenotype and reduced expression of the BES1-target gene SAUR-AC1 (Fig. 3h-j) . Taken together, these results demonstrate that dephosphorylation by the BSU1-related phosphatases is the primary mechanism of BIN2 inactivation and is an essential step in BR signal transduction.
The Arabidopsis genome encodes ten GSK3/shaggy-like kinases (AtSKs), which are classified into four subgroups (Fig. 4a) . A triple-knockout mutant for group II AtSKs, including BIN2, shows increased cell elongation but still accumulates phosphorylated BES1 and responds to brassinolide, indicating that other GSK3-like kinases also function in BR signalling 2, 22 . We performed an interaction study between BZR1 and nine AtSKs representing four subgroups, and found that all six AtSKs of subgroups I and II interact with BZR1 in yeast two-hybrid assays (Fig. 4b) . We further examined the function of AtSK12 as a representative of subgroup I AtSKs in BR signalling. BiFC assays showed that, in Arabidopsis, AtSK12 interacts with BZR1 as does BIN2, and that deletion of the C-terminal 29 amino acids of AtSK12 abolished the interaction with BZR1 ( Fig. 4c; Supplementary Information,  Fig. S9a ). Transgenic plants overexpressing AtSK12 or AtSK12 E297K (corresponding to the bin2-1 gain-of-function mutation) displayed similar dwarf phenotypes to plants overexpressing BIN2 or bin2-1 (Fig. 4d) 
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. Similarly to BIN2, AtSK12 strongly phosphorylates BZR1 in vitro (Fig. 4e) , is localized in both the cytoplasm and nucleus independently of BR treatment ( Supplementary Information, Fig. S9b) , is stabilized by the BR biosynthetic inhibitor brassinazole (BRZ; Supplementary Information, Fig. S9c ) and is destabilized by brassinolide or by overexpression of BSU1-YFP (Fig. 4f,  g ). Mass spectrometry analysis indicated that Tyr 233 of AtSK12 (corresponding to Tyr 200 of BIN2) is also phosphorylated ( Supplementary  Information, Fig. S9d ). BR treatment greatly reduced phosphorylation of AtSK12 Tyr 233, indicating a similar mechanism of its regulation by BR to that of BIN2 (Fig. 4h) . These results indicate that BSU1-mediated tyrosine dephosphorylation is a common mechanism shared by at least two of the six GSK3-like kinases that are probably involved in BR signalling.
The functioning of BSU1 upstream of BIN2 suggests that it might be directly regulated by upstream components on the plasma membrane. We tested for direct interaction of BSU1 with BRI1, BAK1 and BSK1 in vitro and found that the MBP-BSU1 protein interacted with BSK1 but not with BRI1 or BAK1 (Fig. 5a) , which is consistent with BSK1 being downstream of BRI1 in the signalling pathway. BiFC assays showed that BSK1 interacts with both BSU1 and BSL1 in vivo (Fig. 5b) , and the interaction was further confirmed by co-immunoprecipitation assays (Fig. 5c) . We have shown previously that BRI1 phosphorylates BSK1 at Ser 230. We found that phosphorylation of BSK1 by BRI1 increased, whereas the mutation BSK1 S230A abolished, the binding of BSK1 to BSU1 (Fig. 5d) , indicating that BRI1 phosphorylation of BSK1 at Ser 230 increases the interaction of BSK1 with BSU1. These results demonstrate that BRI1 phosphorylation of BSK1 Ser 230 promotes BSK1 binding to BSU1. Such interaction with BSK1 is likely to mediate BR activation of BSU1 in vivo, although we did not detect an effect of BSK1 on BSU1 activity in vitro (data not shown).
Together, our results bridge the last major gaps and elucidate a complete BR signalling pathway that involves several steps of sequential phosphorylation/dephosphorylation, transducing the signal from the BRI1-BAK1 receptor kinase complex to BSK1, BSU1, BIN2, and BZR1 and BZR2 (Fig. 5e ). In the absence of BR, BZR1 and BZR2 are inhibited by BIN2-catalysed phosphorylation and are consequently excluded from the nucleus due to binding by the 14-3-3 proteins 2 , loss of DNA binding activity 15, 22 and degradation by the proteasome 20 . BR binding to the extracellular domain of BRI1 activates BRI1 kinase through ligand-induced association and trans-phosphorylation with its co-receptor kinase BAK1 (ref. 12). BRI1 then phosphorylates BSK1 kinase at Ser 230 (ref. 10) , and this phosphorylation promotes BSK1 interaction with, and activation of, BSU1. On activation, BSU1 dephosphorylates BIN2 at its pTyr 200 residue to inhibit BIN2 kinase activity, allowing accumulation of unphosphorylated BZR1 and BZR2 in the nucleus where they regulate BR-responsive gene expression and plant growth ( Fig. 5e; Supplementary Information, Fig. S1b) .
Signal transduction through cell surface receptor kinases is a fundamental mechanism for cellular regulation in living organisms. BRI1 is a member of the large family of leucine-rich-repeat receptor-like kinases (LRR-RLK), with over 220 members in Arabidopsis and 400 in rice 28 . Only a handful of these RLKs have been studied 29 . The BR signalling pathway described in this study represents the first complete RLK-mediated signalling pathway S230A was incubated with GST-BRI1-K or GST for 2 h. An overlay assay was performed as described in a. Full scans of immunoblots are shown in Supplementary  Information, Fig. S12 . (e) The BR signal transduction pathway. Filled objects indicate components in active states and open objects, inactive states. In the absence of BR (-BR), BRI1 is kept in an inactive form with help from its inhibitor BKI1; consequently BAK1, BSK1 and BSU1 are inactive, while BIN2 is active and phosphorylates BZR1 and BZR2 (BZR1/2), leading to loss of their DNA-binding activity, exclusion from the nucleus by the 14-3-3 proteins and degradation by the proteasome. In the presence of BR (+ BR), BR binding to the extracellular domain of BRI1 induces dissociation of BKI1 and association and inter-activation between BRI1 and BAK1. Activated BRI1 then phosphorylates BSK1, which in turn dissociates from the receptor complex and interacts with, and presumably activates, BSU1. BSU1 inactivates BIN2 by dephosphorylating it at pTyr 200, allowing accumulation of unphosphorylated BZR1/2, probably with help from an unknown phosphatase. Unphosphorylated BZR1/2 accumulates in the nucleus and binds to promoters to regulate the expression of BR-target genes, leading to cellular and developmental responses.
in plants and provides a model for understanding other signal transduction pathways in plants.
Each BR signalling component in Arabidopsis is encoded by a small gene family with three to six members, which have similar biochemical functions. BRI1 is the only essential gene for BR signalling that has been identified by recessive mutations, yet two BRI1 homologues, BRL1 and BRL3, seem to mediate BR signalling in a tissue-specific manner 11, 30, 31 . All the other components have been identified either by gain-of-function mutations or by proteomic/biochemical approaches 10 . Single knockout of BIN2, BZR1, BES1, BSU1 or BSK1 caused no obvious phenotype or a very subtle growth phenotype, suggesting genetic redundancy among the members of each gene family. Our transgenic and biochemical studies provide strong evidence that six Arabidopsis GSK3s (groups I and II) are involved in BR signalling (Fig. 4) , and our loss-of-function data show that all four members of the BSU1 family contribute to BR signalling (Fig. 3h-j) . As such, each step of BR signal transduction seems to be carried out by several members of the gene family, although only the founding member of each family is presented in the conceptual model of BR signal transduction (Fig. 5e) . In contrast, microarray data indicates very similar ubiquitous expression patterns for BRI1, BSK1, BSU1, BSL1 and BZR1 ( Supplementary Information, Fig. S10 ) 14, 31 , supporting their major roles in BR responses.
Our study reveals BSU1-mediated pTyr 200 dephosphorylation as the primary mechanism for regulating plant GSK3s in the BR signalling pathway. This tyrosine residue is absolutely conserved in all GSK3s identified so far, and its phosphorylation is required for kinase activity in Dictyostelium discoideum and mammals 27, 32, 33 . However, the phosphatase required for this regulation has not been identified in these systems 27, [33] [34] [35] . BSU1 represents the first phosphatase that mediates dephosphorylation of this conserved tyrosine residue of GSK3s. BSU1 contains an N-terminal Kelch-repeat domain and a C-terminal phosphatase domain 14 , which dephosphorylates both pSer/Thr and pTyr residues ( Supplementary  Information, Figs S2b, c and S11 ). The phosphatase domain of BSU1 shares about 45% sequence identity with mammalian PP1 (protein phosphatase-1). Interestingly, PP1 expressed in Escherichia coli shows both Tyr and Ser/Thr phosphatase activity, although native PP1 expressed in mammalian cells is inactive on pTyr due to inhibition by inhibitor-2 (ref. 36 ). It will be interesting to see if BSU1-related phosphatases mediate tyrosine dephosphorylation of GSK3s in mammals and other species.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/. Phenotypic analysis of hypocotyls. Sterilized Arabidopsis seeds were planted on × 0.5 MS agar plates. Cold-treated agar plates were kept under white light for 6 h and plants were vertically grown in the dark for 5 days. The seedlings were photocopied by digital camera.

Materials. The bri1-5 mutant is in
In vitro kinase and phosphatase assays. MBP-BZR1 and GST-BIN2 proteins were expressed and purified from E. coli, and maltose or glutathione was removed from the proteins by ultrafiltration using Centricon 50 (Amicon Ultra, Millipore). To prepare fully phosphorylated BZR1 proteins, MBP-BZR1 was incubated with GST-BIN2 at a 1:1 ratio in the kinase buffer (20 mM Tris at pH 7.5, 1 mM MgCl 2 , 100 mM NaCl and 1 mM DTT) containing ATP (100 μM) at 30°C overnight.
The protein mixture was incubated with glutathione Sepharose beads to remove GST-BIN2, then with amylose beads to purify MBP-pBZR1. Partially phosphorylated 32 P-labelled pBZR1 and pBZR2 were prepared using the same method but MBP-BZR1 or MBP-BZR2 was incubated with GST-BIN2 at a 15:1 ratio for 3 h in the presence of [γ- In vitro BIN2 inhibition assays were performed by 3 h co-incubation of MBP-BZR1, GST-BIN2, GST-BSU1 and [γ- ).
Immunoprecipitation and co-immunoprecipitation. Plant materials were ground with liquid nitrogen and resuspended in IP buffer (50 mM Tris at pH 7.5, 150 mM NaCl, 5% Glycerol, 1% Triton X-100, 1 mM PMSF and 1 × protease inhibitor cocktail from Sigma). Filtered protein extracts were centrifuged at 20,000g for 10 min and the resulting supernatant was incubated with an anti-GFP antibody bound Protein A beads or anti-Myc agarose beads for 1 h. Beads were washed five times with washing buffer (50 mM Tris at pH 7.5, 150 mM NaCl, 0.2% Triton X-100, 1 mM PMSF and 1 × Protease inhibitor cocktail). The beads were resuspended with a small volume of kinase buffer and used for in vitro phosphatase assays, or immunoprecipitated proteins were eluted with buffer containing 2% SDS and analysed by SDS-PAGE and immunoblotting.
Dephosphorylation of BIN2 at pTyr 200. GST-BIN2 or GST-bin2-1 was incubated with MBP-BSU1 or BSU1-YFP beads for 3 h and subjected to immunoblotting. The pTyr 200 residue of BIN2 was detected by an anti-phospho-GSK3α/β (Tyr 279/216) monoclonal antibody (5G-2F, Millipore; 1:2,000) and re-probed with an HRP-conjugated anti-GST antibody (Santa Cruz Biotechnology; 1:2,500).
The det2 plants were treated with brassinolide (0.2 μM) after 1 h incubation with MG132 (10 μM). Anti-BIN2 serum was developed in rabbits using GST-BIN2
as an immunogen. A monoclonal anti-GSK3α/β antibody was purchased from Invitrogen (1:2,000).
Site-directed mutagenesis. Point mutations were generated by site-directed mutagenesis PCR according to the manufacturer's protocol (Stratagene reverse, 5-GTATTGTCCATGGAT ATTGCCGAAGACTTTGATTG-3.
Overexpression and knockout/down of BSU1-related phosphatases. Full-length cDNAs of BSU1 and BSL1 without stop codons were amplified by PCR using genespecific primers (BSU1 forward, 5-caccATGGCTCCTGATCAATCTTATCAATA T-3; BSU1 reverse, 5-TTCACTTGACTCCCCTCGAGCTGGAGTAG-3; BSL1 forward, 5-caccATGGGCTCGA AGCCTTGGCTACATCCA-3; BSL1 reverse, 5-GATGTATGCAAGCGAGCTTCTGTCAAAA TC-3) from reverse transcription of Arabidopsis mRNA and cDNA clone (RIKEN, RAFL09-11-J01), respectively. The cDNAs were cloned into pENTR/SD/D-TOPO vectors (Invitrogen) and subcloned into gateway compatible pEarleyGate 101, pGWB17, pGWB20 or BiFC vectors 15 by using LR reaction kit (Invitrogen). To test phenotypic suppression of bri1-116 and bin2-1 by BSU1, 35S::BSU1-YFP single plant was crossed into bri1-116 and bin2-1. The phenotype of F 3 double homozygous plants was analysed. To generate the quadruple loss-of-function mutant of bsu1,bsl1/BSL2,3-amiRNA, the double mutant of bsu1-1 (SALK_030721) and bsl1-1 (SALK_051383) 37 was transformed with an artificial microRNA construct targeting both BSL2 and BSL3 genes (BSL2,3-amiRNA), which was designed by the Web MicroRNA Designer 2 (ref. 38), using the oligonucleotide 5-TATTCATCAAAAAGGCGCGTG-3 and plasmid pRS300 (ref. 38). The DNA fragment of amiRNA was cloned into pEarleyGate 100 (pEG100) by using the Gateway cloning kit (Invitrogen), yielding BSL2,3-amiRNA/pEG100. The binary vector constructs were introduced into Agrobacterium strain GV3101 by electroporation and transformed into Arabidopsis by using the floral dipping method.
Quantitative real time PCR. SAUR-AC1 mRNA was analysed using quantitative real-time PCR as described by Gampala et al. 15 using gene-specific primers (SAUR-AC1 forward, 5-AAGAGGATTCATGGCGGTCTATG-3; SAUR-AC1 reverse, 5-GTATTGTTAAGCCGCCCA TTGG-3). UBC (UBC forward, 5 -CAAATCCAAAACCCTAGAAACCGAA-3; UBC reverse, 5-ATCTC CCGTAGGACCTGCACTG-3) was used to normalize the loading.
Yeast two-hybrid assays of AtSKs. The cDNA clones of AtSKs were obtained from ABRC (http://www.biosci.ohio-state.edu/pcmb/Facilities/abrc/abrchome. htm) 39 . All AtSK cDNAs were subcloned into gateway compatible pGADT7 vector (Clontech). Nine AtSKs-pGADT7 constructs and empty pGADT7 vector were transformed into cells containing BZR1-pGBKT7. Yeast clones were grown on synthetic dropout (SD) or SD-histidine containing 3-amino-1, 2, 4-triazole (2.5 ~ 10 mM).
In vitro kinase assay of AtSK12. GST-AtSK12 (1 μg) was incubated with MBP-BZR1 (2 μg), ATP (100 μM) and [γ- The reaction was terminated by addition of 2 × SDS loading buffer and separated by 7.5% SDS-PAGE. Gel was stained with Coomassie brilliant blue followed by drying. The radioactivity was analysed by Phospho-image screen using Typhoon 8600 Scanner (GE Healthcare). Figure S12 Full scan data of immunoblot and in vitro kinase/phosphatase assays. Correct bands are indicated by red asterisk.
Determination of in vitro
